Loading...

Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsy

BACKGROUND: Multi-step testing might enhance performance of the prostate cancer diagnostic pipeline. Using PSA >1 ng/ml for first-line risk stratification and the Stockholm 3 Model (S3M) blood-test >10% risk of Gleason Score > 7 prostate cancer to inform biopsy decisions has been suggested....

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMC Urol
Main Authors: Nordström, Tobias, Adolfsson, Jan, Grönberg, Henrik, Eklund, Martin
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2017
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5627473/
https://ncbi.nlm.nih.gov/pubmed/28974201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-017-0281-8
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!